Trom Industries Receives Purchase Order Worth INR 1,87,68,340.00 from Zydus Pharmaceuticals
Trom Industries Limited announced the receipt of a purchase order from M/s. Zydus Pharmaceuticals Limited. The contract involves the supply and design, installation, testing, and commissioning of a Solar Rooftop Power Plant with a capacity of 710 KW.The order, which falls under the nature of supplying and designing a Solar Rooftop Power Plant of 710 KW, was received from a domestic entity designated as SEZ. The total order value is reported to be INR 1,87,68,340.00.
The company stated that the supply under this order is expected to be completed within a period of 12 months.
Financial details of the purchase order received from M/s. Zydus Pharmaceuticals Limited are summarized below:
| Particulars | Details |
|---|---|
| Name of Party | M/s. Zydus Pharmaceuticals Limited |
| Scope of Work | Supply and Design, Installation, Testing, Commissioning of Solar Rooftop Power Plant of 710 KW |
| Entity Type | Domestic Entity (SEZ) |
| Order Value | INR 1,87,68,340.00 |
| Completion Timeline | Within 12 months |
The details provided indicate that there is no interest from the promoter or the promoter group in the entity that awarded the order. Furthermore, the purchase order does not constitute a related party transaction.
Trom Industries Limited's corporate office is located at 421, 4th Floor, Pramukh Tangent, Sargasan, Cross Road, Gandhinagar - 382421, Gujarat. Its factory address is at B-53/A, G.I.D.C Electronic Estate, Sector-25, Gandhinagar - 382024, Gujarat, India. The announcement regarding this order was made on April 11, 2026.
TROM Stock Price Movement
On Friday, Trom Industries Limited shares rallied, closing up 3.90% to settle at ₹73.2. The stock saw total trading volume reach 4,800 shares during the session.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.